Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stannous Fluoride for Gingivitis Control
NCT05916508Completed
- Sponsor
- Procter & Gamble
- Start
- Oct 2020
- Primary completion
- Nov 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, double-blind trial of stannous fluoride in gingivitis (3 arms), sponsored by Procter & Gamble. Primary endpoint: Löe-Silness Gingivitis Index at Week 4. Started Oct 2020; status: completed.
02
Drugs
stannous fluoride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT05916508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05916508.